Accredited to ISO/IEC 17043:2010, Provider 7805
Non-molecular screening and diagnostic testing for the haemoglobinopathies
PURPOSE OF PROGRAMME:
Purpose of the programme: Assessment of the performance of participants using non-molecular techniques for the screening and diagnostic testing for the haemoglobinopathies, using liquid blood specimens. The programme includes qualitative and quantitative testing and participants may register for individual parts of the programme according to their needs.
|Assessment of Hb A2 and Hb F in terms of the participant’s reference range (AH)|
|Hb variant identification: adult (AH) specimens|
|Hb variant identification: liquid newborn (LN) specimens|
|Interpretation of results (AH and LN)||ml|
|Quantification of Hb A2 Hb F and Hb S (AH)|
|Sickle screening (SS) specimens|
MATERIAL PROVIDED: Whole Blood
DISTRIBUTIONS PER YEAR: 6
SAMPLES PER DISTRIBUTION: 3 (SS), 3 (AH), 2 (LN)
FREQUENCY OF DISTRIBUTION: Bi-monthly as per the published Distribution Schedule.
PROGRAMME OF ANALYSIS:
Online operation for entry of results and return of reports.
Quantitative Data is analysed against a Method Trimmed Mean. Qualitative Data is assessed against a Consensus Target
For information on Performance Scoring and Monitoring see the UK NEQAS Haematology Participants’ Manual which is available to download from www.ukneqash.org.
UK NEQAS Haematology is the expert centre within the UK National External Quality Assessment Service (UK NEQAS) for all aspects of Haematology diagnostic testing external quality assessment (EQA), with almost 5,000 UK and international registrations and a further 3,000 individual practitioners in our educational morphology programme. UK NEQAS Haematology provides a wide range of EQA services for automated cell counting, blood morphology, haemoglobinopathies and other inherited red cell disorders. Participants may select the combination that fits their laboratory profile, making the Scheme flexible and adaptable to participants’ needs.